首页> 外文期刊>Oxidative Medicine and Cellular Longevity >Antioxidant Therapies for Alzheimer's Disease
【24h】

Antioxidant Therapies for Alzheimer's Disease

机译:阿尔茨海默氏病的抗氧化疗法

获取原文
           

摘要

Alzheimer’s disease (AD) is the most common neurodegenerative disease featuring progressive impairments in memory, cognition, and behavior and ultimately leads to death. The histopathological changes of Alzheimer’s disease include neuronal and synaptic loss, formation of extracellular senile plaques and intracellular neurofibrillary tangles in brain. Multiple lines of evidence indicate that oxidative stress not only strongly participates in an early stage of Alzheimer’s disease prior to cytopathology, but plays an important role in inducing and activating multiple cell signaling pathways that contribute to the lesion formations of toxic substances and then promotes the development of Alzheimer’s disease. Many years of studies show that antioxidant therapies have enjoyed general success in preclinical studies. Therefore, this paper mainly focuses on the recent developments of common used antioxidant therapies for Alzheimer’s disease and thus provides indications for future potential antioxidant therapeutic strategies of neurodegenerative diseases.
机译:阿尔茨海默氏病(AD)是最常见的神经退行性疾病,具有记忆,认知和行为的进行性损害,最终导致死亡。阿尔茨海默氏病的组织病理学变化包括神经元和突触丧失,脑中细胞外老年斑和细胞内神经原纤维缠结的形成。多种证据表明,氧化应激不仅在细胞病理学之前强烈参与了阿尔茨海默氏病的早期阶段,而且在诱导和激活多种细胞信号通路中起着重要作用,这些信号通路促进了有毒物质的病变形成,进而促进了发育。阿尔茨海默氏病。多年的研究表明,抗氧化剂疗法在临床前研究中获得了普遍的成功。因此,本文主要关注阿尔茨海默氏病常用抗氧化剂治疗的最新进展,从而为神经退行性疾病的潜在抗氧化剂治疗策略提供了指示。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号